UBS Raises Price Target on Zimmer Biomet Holdings (ZBH) Following 2Q Earnings Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Zimmer Biomet Holdings (ZBH): Accelerating Growth To Market Rates - Jefferies
August 2, 2016 7:26 AM EDTJefferies analyst, Raj Denhoy, reiterated his Buy rating on shares of Zimmer Biomet (NYSE: ZBH) after a review of 2Q growth rates for the ortho players shows that ZBH made tangible progress in closing the gap between the company's growth and the market. After adjusting for selling day differences, acquisitions, and currency, knees grew ~4.5% and hips... More
Jefferies Raises Price Target on Zimmer Biomet Holdings (ZBH) Following 2Q
July 29, 2016 7:51 AM EDTJefferies reiterated a Buy rating on Zimmer Biomet Holdings (NYSE: ZBH), and raised the price target to $150.00 (from $135.00), following the company's 2Q earnings report. GM was down 60bp, though OM was up 160bp as spending in SG&A was down 220bp. ZBH reported an... More
